University Hospital of North-Norway
The Research Group for Child and Adolescents Health at UiT the Arctic University of Norway (UiT)/University Hospital of Northern Norway (UNN) in Tromsø is working to gain new insights into the health and diseases of children and young people to contribute to improving preventive methods and treatments. Link: https://uit.no/research/pediatrics
The research group includes university employees and other researchers affiliated with the Child and Adolescent Health Department including the Child and Adolescent Psychiatric Department (UNN), as well as those with pure university positions linked to the Pediatric Research Laboratory at the Faculty of Health Science of the UiT. Clinical research is done i cooperation with the Clinicalo research department at UN
The strategy of the research group is based on the research strategy of the Faculty of Health Sciences, UiT, and UNN/Northern Norway Regional Health Authority.
Primary Goal (long-term)
Generate new knowledge about the somatic and mental health and diseases of children and youth to better prevent and treat them.
Research Fields
- Infections (biofilm, staphylococci, microbiome)
- Cancer (neuroblastoma, clinical cancer research)
- Rheumatology, neonatology
- Mental disorders
- Most projects involve collaboration with other groups on-site and internationally
Diversity
There is academic diversity in the research group, including representatives from various backgrounds:
- Natural scientist/engineer, physician
- Psychologist, nurse
- Research line student, master's student
- PhD candidate
- Postdoctoral researcher/researcher/associate professor
- Professor
Funding
Funding sources include internal funds from UNN/UiT, competitive grants from UNN/UiT, allocations from Helse Nord (somatic, mental, telemedical), grants from Norwegian Cancer Society, Norwegian Childhood Cancer Society, Norwegian Research Council, European Union etc.
Research sponsored by industry as well as by academic or other institutions are in Tromsø organised at one of the three clinical departments, Pediatric university lab and at the Clinical research department.
Personel
Several experienced nurses hold part-time positions related to research on children, with coordinator Malen Otelie Nørby. Senior consultant Trond Flægstad holds a part-time position related to NorPedMed. Additionally, we have several consultants in professorial positions and in associate professorial positions at the UiT, engaging in research.
The department has extensive experience in both researcher-initiated studies and industry-initiated clinical trials.
Professor Ellen Nordal (chair research committee of the Child and Adolescent Psychiatric Department (UNN)) and professor em/consultant at the Clinical research department.
Study nurse Tonje Løvli and coordinator Malen Otelie Nørby
Professor Claus Klingenberg, chair of the Research Group for Child and Adolescents Health at UiT the Arctic University of Norway (UiT)/University Hospital of Northern Norway (UNN)
—website under construction, the list of ongoing studies is therefore not yet complete—
Ongoing studies
| REK | Study | Status | Links |
|---|---|---|---|
| 2022-502238-22-00 | A phase 3 randomized, open-label induction, double-blind maintenance, parallel-group, multicenter protocol to evaluate the efficacy, safety and pharmacokinetics of Guselkumab in pediatric participants with moderately to severely active ulcerative colitis (Quasar Jr) | Open | |
| 0000/1003 | Master protocol: A phase 3, multicenter, randomized, platform study of p19 inhibition of the IL-23 pathway to establich efficacy in pediatric Crohn`s disease. A study of Guselkumab in pediatric participants with moderately to severely active Crohn`s disease (Macaroni). | Open | |
| 2024-511472-32-00 | Master protocol: A phase 3, multicenter, randomized, platform study of p19 inhibition of the IL-23 pathway to establich efficacy in pediatric Crohn`s disease. ISA title: A phase 3, multicenter, randomized, clinical study to evaluate Mirikizumab in pediatric Crohn`s diseases (Macaroni). | Open | |
| 2018/1495 | INSTAR: Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing | Open | — |
| 2018/385 | POPART: Prophylactic oropharyngeal surfactant for preterm infants: a randomised trial | Closed | — |
| 2014/1633 | A randomised, double-blind, placebo-controlled, parallel-group, multi-centre 24-week study to evaluate the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe eosinophilic asthma on markers of asthma control | Closed | — |
